{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:52:20Z","timestamp":1790009540869,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Acute kidney injury (AKI) impairs renal function in the short term and may eventually progress to chronic kidney disease (CKD) in the long term. The activation of Smad3 and an imbalance in hypoxia-inducible factors-\u03b1 (HIF-\u03b1) expression constitute vital mechanisms leading to the AKI-CKD transition. We have designed a Smad3-targeted Proteolysis-Targeting Chimera (PROTAC) named P1705434, which recruited VHL to degrade Smad3 and meanwhile stable HIF-2\u03b1 levels. We established a cisplatin nephrotoxicity model and folic acid nephropathy (FAN) model to explore its role and possible mechanisms in the early stage and development of AKI. The results demonstrated that P1705434 alleviated inflammation and fibrosis in progressing AKI by degrading Smad3 and increasing HIF-2\u03b1. This was confirmed in both the cisplatin nephrotoxicity and FAN mice models, as evidenced by the reduction percentage of maladaptive proximal tubular cells (PT) and down-regulation of the TNF pathway, which ameliorated injury in S3-PT. Furthermore, we identified a transitional collecting duct (tCD) cell type that had a trend to differentiate into fibroblast but P1705434 treatment reduces the propensity of tCD cells and mitochondrial injury in CD cells by up-regulating the oxidative phosphorylation (OXPHOS) pathway.<\/jats:p>","DOI":"10.1038\/s41419-026-08726-w","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T16:45:00Z","timestamp":1775839500000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["VHL-recruiting PROTAC attenuates AKI-CKD transition via simultaneous degradation of Smad3 and stabilization of HIF-2\u03b1"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3088-149X","authenticated-orcid":false,"given":"Yuyi","family":"Ruan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6862-1941","authenticated-orcid":false,"given":"Sydney C. W.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4560-4599","authenticated-orcid":false,"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5016-6653","authenticated-orcid":false,"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"8726_CR1","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/S0140-6736(19)32563-2","volume":"394","author":"C Ronco","year":"2019","unstructured":"Ronco C, Bellomo R, Kellum JA. Acute kidney injury. Lancet. 2019;394:1949\u201364.","journal-title":"Lancet"},{"key":"8726_CR2","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1681\/ASN.2012030222","volume":"23","author":"C Hsu","year":"2012","unstructured":"Hsu C. Yes, AKI Truly Leads to CKD. J Am Soc Nephrol. 2012;23:967\u20139.","journal-title":"J Am Soc Nephrol"},{"key":"8726_CR3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2016.48","volume":"12","author":"X-M Meng","year":"2016","unstructured":"Meng X-M, Nikolic-Paterson DJ, Lan HY. TGF-\u03b2: the master regulator of fibrosis. Nat Rev Nephrol. 2016;12:325\u201338.","journal-title":"Nat Rev Nephrol"},{"key":"8726_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41581-019-0247-z","volume":"16","author":"MT James","year":"2020","unstructured":"James MT, Bhatt M, Pannu N, Tonelli M. Long-term outcomes of acute kidney injury and strategies for improved care. Nat Rev Nephrol. 2020;16:193\u2013205.","journal-title":"Nat Rev Nephrol"},{"key":"8726_CR5","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/s41581-019-0182-z","volume":"15","author":"J Sch\u00f6del","year":"2019","unstructured":"Sch\u00f6del J, Ratcliffe PJ. Mechanisms of hypoxia signalling: new implications for nephrology. Nat Rev Nephrol. 2019;15:641\u201359.","journal-title":"Nat Rev Nephrol"},{"key":"8726_CR6","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.jacbts.2020.05.006","volume":"5","author":"M Packer","year":"2020","unstructured":"Packer M. Mutual antagonism of hypoxia-inducible factor isoforms in cardiac, vascular, and renal disorders. JACC Basic Transl Sci. 2020;5:961\u20138.","journal-title":"JACC Basic Transl Sci"},{"key":"8726_CR7","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1097\/01.ASN.0000017223.49823.2A","volume":"13","author":"C Rosenberger","year":"2002","unstructured":"Rosenberger C, Mandriota S, J\u00fcrgensen JS, Wiesener MS, H\u00f6rstrup JH, Frei U, et al. Expression of Hypoxia-Inducible Factor-1\u03b1 and -2\u03b1 in Hypoxic and Ischemic Rat Kidneys. J Am Soc Nephrol. 2002;13:1721.","journal-title":"J Am Soc Nephrol"},{"key":"8726_CR8","doi-asserted-by":"publisher","first-page":"F271","DOI":"10.1152\/ajprenal.00071.2006","volume":"291","author":"VH Haase","year":"2006","unstructured":"Haase VH. Hypoxia-inducible factors in the kidney. Am J Physiol Ren Physiol. 2006;291:F271\u2013281.","journal-title":"Am J Physiol Ren Physiol"},{"key":"8726_CR9","first-page":"1","volume":"7","author":"M He","year":"2022","unstructured":"He M, Cao C, Ni Z, Liu Y, Song P, Hao S, et al. PROTACs: great opportunities for academia and industry (an update from 2020 to 2021). Signal Transduct Target Ther. 2022;7:1\u201364.","journal-title":"Signal Transduct Target Ther"},{"key":"8726_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cbpa.2019.02.022","volume":"50","author":"S-L Paiva","year":"2019","unstructured":"Paiva S-L, Crews CM. Targeted protein degradation: elements of PROTAC design. Curr Opin Chem Biol. 2019;50:111\u20139.","journal-title":"Curr Opin Chem Biol"},{"key":"8726_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01434-3","volume":"21","author":"X Li","year":"2022","unstructured":"Li X, Pu W, Zheng Q, Ai M, Chen S, Peng Y. Proteolysis-targeting chimeras (PROTACs) in cancer therapy. Mol Cancer. 2022;21:99.","journal-title":"Mol Cancer"},{"key":"8726_CR12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s13578-022-00936-x","volume":"12","author":"J Yang","year":"2022","unstructured":"Yang J, Ruan Y, Wang D, Fan J, Luo N, Chen H, et al. VHL-recruiting PROTAC attenuates renal fibrosis and preserves renal function via simultaneous degradation of Smad3 and stabilization of HIF-2\u03b1. Cell Biosci. 2022;12:203.","journal-title":"Cell Biosci"},{"key":"8726_CR13","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1681\/ASN.2018020125","volume":"29","author":"H Wu","year":"2018","unstructured":"Wu H, Malone AF, Donnelly EL, Kirita Y, Uchimura K, Ramakrishnan SM, et al. Single-cell transcriptomics of a human kidney allograft biopsy specimen defines a diverse inflammatory response. J Am Soc Nephrol. 2018;29:2069.","journal-title":"J Am Soc Nephrol"},{"key":"8726_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ado2849","volume":"10","author":"Y Muto","year":"2024","unstructured":"Muto Y, Dixon EE, Yoshimura Y, Ledru N, Kirita Y, Wu H, et al. Epigenetic reprogramming driving successful and failed repair in acute kidney injury. Sci Adv. 2024;10:eado2849.","journal-title":"Sci Adv"},{"key":"8726_CR15","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/nm.2807","volume":"18","author":"TA Wynn","year":"2012","unstructured":"Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med. 2012;18:1028\u201340.","journal-title":"Nat Med"},{"key":"8726_CR16","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1159\/000527713","volume":"47","author":"J Huang","year":"2022","unstructured":"Huang J, Lai W, Li M, Li C, Lou T, Peng H, et al. SIS3 alleviates cisplatin-induced acute kidney injury by regulating the LncRNA Arid2-IR-Transferrin receptor pathway. Kidney Blood Press Res. 2022;47:729\u201341.","journal-title":"Kidney Blood Press Res"},{"key":"8726_CR17","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/j.1523-1755.2004.00779.x","volume":"66","author":"K Inazaki","year":"2004","unstructured":"Inazaki K, Kanamaru Y, Kojima Y, Sueyoshi N, Okumura K, Kaneko K, et al. Smad3 deficiency attenuates renal fibrosis, inflammation,and apoptosis after unilateral ureteral obstruction. Kidney Int. 2004;66:597\u2013604.","journal-title":"Kidney Int"},{"key":"8726_CR18","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1172\/JCI69073","volume":"124","author":"PP Kapitsinou","year":"2014","unstructured":"Kapitsinou PP, Sano H, Michael M, Kobayashi H, Davidoff O, Bian A, et al. Endothelial HIF-2 mediates protection and recovery from ischemic kidney injury. J Clin Invest. 2014;124:2396\u2013409.","journal-title":"J Clin Invest"},{"key":"8726_CR19","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.3390\/antiox11091810","volume":"11","author":"CD Bondi","year":"2022","unstructured":"Bondi CD, Rush BM, Hartman HL, Wang J, Al-Bataineh MM, Hughey RP, et al. Suppression of NRF2 Activity by HIF-1\u03b1 Promotes Fibrosis after Ischemic Acute Kidney Injury. Antioxidants. 2022;11:1810.","journal-title":"Antioxidants"},{"key":"8726_CR20","doi-asserted-by":"publisher","unstructured":"Li X, Jiang B, Zou Y, Zhang J, Fu Y-Y, Zhai X-Y Roxadustat (FG-4592) Facilitates Recovery From Renal Damage by Ameliorating Mitochondrial Dysfunction Induced by Folic Acid. Front Pharmacol 2022;12. https:\/\/doi.org\/10.3389\/fphar.2021.788977.","DOI":"10.3389\/fphar.2021.788977"},{"key":"8726_CR21","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1042\/CS20171625","volume":"132","author":"Y Yang","year":"2018","unstructured":"Yang Y, Yu X, Zhang Y, Ding G, Zhu C, Huang S, et al. Hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) protects against cisplatin-induced acute kidney injury. Clin Sci. 2018;132:825\u201338.","journal-title":"Clin Sci"},{"key":"8726_CR22","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nchembio.1858","volume":"11","author":"DP Bondeson","year":"2015","unstructured":"Bondeson DP, Mares A, Smith IED, Ko E, Campos S, Miah AH, et al. Catalytic in vivo protein knockdown by small-molecule PROTACs. Nat Chem Biol. 2015;11:611\u20137.","journal-title":"Nat Chem Biol"},{"key":"8726_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.chembiol.2017.09.009","volume":"25","author":"GM Burslem","year":"2018","unstructured":"Burslem GM, Smith BE, Lai AC, Jaime-Figueroa S, McQuaid DC, Bondeson DP, et al. The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study. Cell Chem Biol. 2018;25:67\u201377.e3.","journal-title":"Cell Chem Biol"},{"key":"8726_CR24","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41581-019-0110-2","volume":"15","author":"PM-K Tang","year":"2019","unstructured":"Tang PM-K, Nikolic-Paterson DJ, Lan H-Y. Macrophages: versatile players in renal inflammation and fibrosis. Nat Rev Nephrol. 2019;15:144\u201358.","journal-title":"Nat Rev Nephrol"},{"key":"8726_CR25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cmet.2011.04.013","volume":"14","author":"H Yadav","year":"2011","unstructured":"Yadav H, Quijano C, Kamaraju AK, Gavrilova O, Malek R, Chen W, et al. Protection from Obesity and Diabetes by Blockade of TGF-\u03b2\/Smad3 Signaling. Cell Metab. 2011;14:67\u201379.","journal-title":"Cell Metab"},{"key":"8726_CR26","doi-asserted-by":"publisher","unstructured":"Thomas LW, Ashcroft M. Exploring the molecular interface between hypoxia-inducible factor signalling and mitochondria. Cell Mol Life Sci CMLS 2019;76. https:\/\/doi.org\/10.1007\/s00018-019-03039-y.","DOI":"10.1007\/s00018-019-03039-y"},{"key":"8726_CR27","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/jcb.25078","volume":"116","author":"WJ Bae","year":"2015","unstructured":"Bae WJ, Shin MR, Kang SK, Zhang-Jun, Kim JY, Lee SC, et al. HIF-2 inhibition supresses inflammatory responses and osteoclastic differentiation in human periodontal ligament cells. J Cell Biochem. 2015;116:1241\u201355.","journal-title":"J Cell Biochem"},{"key":"8726_CR28","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1038\/sj.ki.5000433","volume":"69","author":"D Portilla","year":"2006","unstructured":"Portilla D, Li S, Nagothu KK, Megyesi J, Kaissling B, Schnackenberg L, et al. Metabolomic study of cisplatin-induced nephrotoxicity. Kidney Int. 2006;69:2194\u2013204.","journal-title":"Kidney Int"},{"key":"8726_CR29","doi-asserted-by":"publisher","unstructured":"Hansen J, Sealfon R, Menon R, Eadon MT, Lake BB, Steck B et al. A reference tissue atlas for the human kidney. Bioinformatics. 2020 https:\/\/doi.org\/10.1101\/2020.07.23.216507.","DOI":"10.1101\/2020.07.23.216507"},{"key":"8726_CR30","doi-asserted-by":"crossref","unstructured":"Zhang Y, Feng X-H, Derynck R. Smad3 and Smad4 cooperate with c-Jun\/c-Fos to mediate TFG-b-induced transcription. 1998;394.","DOI":"10.1038\/29814"},{"key":"8726_CR31","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1038\/sj.onc.1204347","volume":"20","author":"F Verrecchia","year":"2001","unstructured":"Verrecchia F, Tacheau C, Schorpp-Kistner M, Angel P, Mauviel A. Induction of the AP-1 members c-Jun and JunB by TGF-beta\/Smad suppresses early Smad-driven gene activation. Oncogene. 2001;20:2205\u201311.","journal-title":"Oncogene"},{"key":"8726_CR32","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1126\/science.aar2131","volume":"360","author":"J Park","year":"2018","unstructured":"Park J, Shrestha R, Qiu C, Kondo A, Huang S, Werth M, et al. Single-cell transcriptomics of the mouse kidney reveals potential cellular targets of kidney disease. Science. 2018;360:758\u201363.","journal-title":"Science"},{"key":"8726_CR33","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41581-021-00394-7","volume":"17","author":"H Scholz","year":"2021","unstructured":"Scholz H, Boivin FJ, Schmidt-Ott KM, Bachmann S, Eckardt K-U, Scholl UI, et al. Kidney physiology and susceptibility to acute kidney injury: implications for renoprotection. Nat Rev Nephrol. 2021;17:335\u201349.","journal-title":"Nat Rev Nephrol"},{"key":"8726_CR34","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1093\/icb\/icz047","volume":"59","author":"IM Sokolova","year":"2019","unstructured":"Sokolova IM, Sokolov EP, Haider F. Mitochondrial mechanisms underlying tolerance to fluctuating oxygen conditions: lessons from hypoxia-tolerant organisms. Integr Comp Biol. 2019;59:938\u201352.","journal-title":"Integr Comp Biol"},{"key":"8726_CR35","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41581-022-00539-2","volume":"18","author":"NA Hukriede","year":"2022","unstructured":"Hukriede NA, Soranno DE, Sander V, Perreau T, Starr MC, Yuen PST et al. Experimental models of acute kidney injury for translational research. Nat Rev Nephrol. 2022;18:277\u201393.","journal-title":"Nat Rev Nephrol"},{"key":"8726_CR36","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1046\/j.1365-2168.1998.00851.x","volume":"85","author":"SC Weight","year":"1998","unstructured":"Weight SC, Furness PN, Nicholson ML. New model of renal warm ischaemia-reperfusion injury for comparative functional, morphological and pathophysiological studies. Br J Surg. 1998;85:1669\u201373.","journal-title":"Br J Surg"},{"key":"8726_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/ki.2009.347","volume":"77","author":"SN Heyman","year":"2010","unstructured":"Heyman SN, Rosenberger C, Rosen S. Experimental ischemia-reperfusion: biases and myths-the proximal vs. distal hypoxic tubular injury debate revisited. Kidney Int. 2010;77:9\u201316.","journal-title":"Kidney Int"},{"key":"8726_CR38","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/ame2.12194","volume":"4","author":"L-J Yan","year":"2021","unstructured":"Yan L-J. Folic acid-induced animal model of kidney disease. Anim Models Exp Med. 2021;4:329\u201342.","journal-title":"Anim Models Exp Med"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08726-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08726-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08726-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T03:14:57Z","timestamp":1779074097000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08726-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8726"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08726-w","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"29 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"460"}}